Sexuality Flashcards
What is the most common cause of erectile dysfunction in older men?
A) Neurologic disease
B) Vascular disease
C) Psychogenic causes
D) Endocrine problems
B) Vascular disease
Erectile dysfunction** is defined as:
A) The inability to maintain an erection during sexual stimulation
B) The inability to achieve or maintain an erection adequate for sexual intercourse
C) Decreased interest in sexual activity
D) Premature ejaculation during sexual intercourse
B) The inability to achieve or maintain an erection adequate for sexual intercourse
Peyronie’s disease** causes:
A) An increase in libido
B) A decrease in testosterone
C) A curvature of the penis due to scarring
D) Increased testicular size
C) A curvature of the penis due to scarring
- Which of the following medications is commonly associated with erectile dysfunction?
A) Antihistamines
B) Antipsychotics
C) Antidepressants
D) All of the above
D) All of the above
Which of the following is a psychogenic cause of erectile dysfunction?
A) Smoking
B) Diabetes
C) Performance anxiety
D) Hypertension
C) Performance anxiety
What is the first-line therapy for erectile dysfunction in older men?
A) Vacuum tumescence devices
B) Phosphodiesterase-5 inhibitors (PDE-5 inhibitors)
C) Testosterone supplementation
D) Intracavernous injections
B) Phosphodiesterase-5 inhibitors (PDE-5 inhibitors)
Low testosterone** in men primarily affects:
A) Erection quality
B) Libido
C) Urination
D) Sleep patterns
B) Libido
. When educating a patient on Viagra (sildenafil), you should emphasize:
A) It can be taken with nitrate medications
B) It works without any penile stimulation
C) It should not be taken with a fatty meal
D) It has no interaction with alcohol
C) It should not be taken with a fatty meal
Testosterone supplementation** is primarily used to improve:
A) Erectile dysfunction
B) Libido in men with low testosterone
C) Ejaculation frequency
D) Vascular health
B) Libido in men with low testosterone
Which condition is a contraindication for the use of PDE-5 inhibitors like Viagra?
A) Hypertension
B) Use of nitrates
C) Diabetes
D) Psychogenic erectile dysfunction
B) Use of nitrates
Postmenopausal vaginal atrophy** can lead to:
A) Increased vaginal lubrication
B) Dyspareunia (painful intercourse)
C) Increased libido
D) Decreased risk of infection
B) Dyspareunia (painful intercourse)
The primary treatment for vaginal atrophy is:
A) Oral contraceptives
B) Topical estrogen therapy
C) Testosterone patches
D) Anticholinergic medications
B) Topical estrogen therapy
Hypoactive sexual desire disorder** in women is defined as:
A) Loss of the ability to achieve orgasm
B) Decreased libido causing distress
C) Pain during intercourse
D) Vaginal dryness
B) Decreased libido causing distress
Vaginal estrogen rings** are often preferred over creams because:
A) They are more affordable
B) They provide better lubrication
C) They are easier to use and more comfortable
D) They cure vaginal infections
C) They are easier to use and more comfortable
A male patient has sudden-onset erectile dysfunction. What is the most likely cause?
A) Psychogenic cause
B) Vascular cause
C) Neurologic cause
D) Endocrine cause
A) Psychogenic cause
Low testosterone** levels in women can lead to:
A) Increased libido
B) Vaginal atrophy
C) Hypoactive sexual desire disorder
D) Increased lubrication
C) Hypoactive sexual desire disorder
Dyspareunia** in older women is most commonly caused by:
A) Hypothyroidism
B) Vaginal atrophy
C) Urinary tract infections
D) Ovarian cysts
B) Vaginal atrophy
Which condition is NOT a risk factor for erectile dysfunction?
A) Hypertension
B) Hyperlipidemia
C) Use of antihypertensive medications
D) Low dietary fiber intake
D) Low dietary fiber intake
Which of the following can negatively impact sexual function in women post-mastectomy?
A) Hormone replacement therapy
B) Adjuvant therapy and body image issues
C) Antibiotics
D) Increased testosterone levels
B) Adjuvant therapy and body image issues
Libido in women is most dependent on which hormone?
A) Estrogen
B) Progesterone
C) Testosterone
D) Cortisol
C) Testosterone
Vascular erectile dysfunction** is most likely to occur in men with:
A) Anxiety disorders
B) Hyperlipidemia
C) Normal testosterone levels
D) Sleep apnea
B) Hyperlipidemia
Postmenopausal women** with a history of breast cancer should avoid:
A) Testosterone therapy
B) Water-based lubricants
C) Topical estrogen
D) Antihistamines
C) Topical estrogen
Nocturnal penile tumescence** testing is used to:
A) Diagnose Peyronie’s disease
B) Confirm psychogenic erectile dysfunction
C) Measure testosterone levels
D) Determine vascular function
B) Confirm psychogenic erectile dysfunction
Addyi** is FDA approved to treat:
A) Postmenopausal vaginal atrophy
B) Erectile dysfunction in older men
C) Hypoactive sexual desire disorder in premenopausal women
D) Vaginal dryness in postmenopausal women
C) Hypoactive sexual desire disorder in premenopausal women
Which of the following is a risk factor for developing erectile dysfunction?
A) Sedentary lifestyle
B) Hyperthyroidism
C) Decreased protein intake
D) Increased physical activity
A) Sedentary lifestyle
Regular intercourse** in postmenopausal women can help:
A) Increase testosterone levels
B) Reduce the risk of breast cancer
C) Prevent vaginal atrophy and maintain vaginal lubrication
D) Prevent osteoporosis
C) Prevent vaginal atrophy and maintain vaginal lubrication
Erectile dysfunction** related to neurologic causes is often associated with:
A) Atherosclerosis
B) Autonomic dysfunction
C) Diabetes
D) Parkinson’s disease
D) Parkinson’s disease
Which condition is NOT a cause of vaginal dryness in older women?
A) Menopause
B) Estrogen deficiency
C) Hypothyroidism
D) High testosterone levels
D) High testosterone levels
Testosterone supplementation** in women is most effective for treating:
A) Hypoactive sexual desire disorder
B) Vaginal atrophy
C) Menopause symptoms
D) Osteoporosis
A) Hypoactive sexual desire disorder
The primary physiological change causing dyspareunia in postmenopausal women is:
A) Vaginal atrophy due to estrogen deficiency
B) Decreased testosterone levels
C) Increased progesterone levels
D) Hyperthyroidism
A) Vaginal atrophy due to estrogen deficiency
Which medication is used for hypoactive sexual desire disorder in premenopausal women?
A) Viagra
B) Caverject
C) Addyi
D) Levitra
C) Addyi
Topical estrogen** for postmenopausal women primarily treats:
A) Erectile dysfunction
B) Decreased libido
C) Vaginal dryness and atrophy
D) Urinary incontinence
C) Vaginal dryness and atrophy
Psychogenic erectile dysfunction** is most commonly associated with:
A) Childhood trauma
B) Hypertension
C) Hyperlipidemia
D) Decreased testosterone
A) Childhood trauma
Which of the following medications should be avoided in combination with Viagra (sildenafil)?
A) Statins
B) Nitrates
C) Beta blockers
D) Diuretics
B) Nitrates
PDE-5 inhibitors such as Viagra work by:
A) Increasing testosterone levels
B) Promoting blood flow to the penis by improving vasodilation
C) Reducing anxiety related to sexual performance
D) Stimulating nerve signals in the spinal cord
B) Promoting blood flow to the penis by improving vasodilation
Which condition is associated with atrophic vaginitis in postmenopausal women?
A) Hyperthyroidism
B) Estrogen deficiency
C) Elevated testosterone levels
D) Increased progesterone levels
B) Estrogen deficiency
Vaginal atrophy** in older women is best treated with:
A) Oral estrogen supplements
B) Topical estrogen creams or rings
C) Testosterone injections
D) Progesterone tablets
B) Topical estrogen creams or rings
Which of the following is a common vascular cause of erectile dysfunction in older men?
A) Diabetes
B) Hypothyroidism
C) Depression
D) Increased testosterone
A) Diabetes
Which of the following is a contraindication for the use of PDE-5 inhibitors like Viagra?
A) Hypothyroidism
B) Use of nitrates
C) Decreased libido
D) Erectile dysfunction due to anxiety
B) Use of nitrates
Low testosterone** in men is most commonly associated with:
A) Decreased libido
B) Enhanced erectile function
C) Vaginal dryness
D) Improved muscle mass
A) Decreased libido
Which of the following is a non-hormonal option for treating vaginal dryness in postmenopausal women?
A) Estradiol tablets
B) Testosterone patches
C) Water-soluble lubricants
D) Oral estrogen supplements
C) Water-soluble lubricants
Addyi** (flibanserin) is FDA approved for:
A) Treating erectile dysfunction in men
B) Increasing testosterone levels in postmenopausal women
C) Treating hypoactive sexual desire disorder in premenopausal women
D) Reducing vaginal atrophy in postmenopausal women
C) Treating hypoactive sexual desire disorder in premenopausal women
Erectile dysfunction** can be an early warning sign of:
A) Parkinson’s disease
B) Atherosclerosis and cardiovascular disease
C) Hypothyroidism
D) Testosterone excess
B) Atherosclerosis and cardiovascular disease
In psychogenic erectile dysfunction, the main contributing factor is:
A) Relationship conflict or performance anxiety
B) Diabetes mellitus
C) Testosterone deficiency
D) Vascular disease
A) Relationship conflict or performance anxiety
Hormonal therapy** with testosterone in women is most effective for:
A) Reducing vaginal atrophy
B) Improving sexual desire and libido
C) Treating dyspareunia
D) Improving lubrication
B) Improving sexual desire and libido
Which of the following medications can cause erectile dysfunction by lowering blood pressure below the critical threshold needed for an erection?
A) Antihistamines
B) Beta-blockers
C) Antidepressants
D) Antibiotics
B) Beta-blockers
Which condition is associated with painful intercourse in postmenopausal women?
A) Hypothyroidism
B) Atrophic vaginitis
C) Elevated testosterone
D) Increased libido
B) Atrophic vaginitis
In evaluating erectile dysfunction, the presence of sleep-associated erections suggests:
A) Neurogenic cause
B) Psychogenic cause
C) Vascular cause
D) Endocrine cause
B) Psychogenic cause
Which of the following conditions may benefit from testosterone supplementation in women?
A) Hypoactive sexual desire disorder
B) Vaginismus
C) Dyspareunia
D) Increased vaginal lubrication
A) Hypoactive sexual desire disorder
